Docusign (NASDAQ:DOCU) Price Target Raised to $70.00

Docusign (NASDAQ:DOCU) had its price target raised by UBS Group from $54.00 to $70.00 in a research note released on Friday, MarketBeat reports. They currently have a neutral rating on the stock.

DOCU has been the topic of several other research reports. Evercore set a $65.00 price target on shares of Docusign in a report on Friday. Robert W. Baird upped their price objective on shares of Docusign from $55.00 to $72.00 and gave the stock a “neutral” rating in a report on Friday. Piper Sandler raised their target price on shares of Docusign from $52.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday. Needham & Company LLC reaffirmed a “hold” rating on shares of Docusign in a research note on Friday. Finally, Wedbush reduced their price target on shares of Docusign from $60.00 to $58.00 and set a “neutral” rating on the stock in a research report on Friday, June 5th. Three investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Docusign presently has an average rating of “Hold” and an average price target of $67.33.

Docusign Price Performance

DOCU opened at $68.41 on Friday. Docusign has a one year low of $40.16 and a one year high of $86.65. The business has a 50 day simple moving average of $55.70 and a two-hundred day simple moving average of $49.90. The firm has a market capitalization of $13.06 billion, a price-to-earnings ratio of 41.71, a PEG ratio of 2.43 and a beta of 0.90.

Docusign (NASDAQ:DOCU) last issued its quarterly earnings data on Thursday, September 3rd. The company reported $1.16 earnings per share for the quarter, topping analysts’ consensus estimates of $1.09 by $0.07. Docusign had a return on equity of 18.29% and a net margin of 9.82%.The firm had revenue of $875.75 million for the quarter, compared to analyst estimates of $867.22 million. During the same period last year, the company earned $0.30 EPS. The business’s quarterly revenue was up 9.4% compared to the same quarter last year. As a group, sell-side analysts expect that Docusign will post 2.03 EPS for the current fiscal year.

Insider Buying and Selling at Docusign

In other news, CEO Allan Thygesen sold 26,250 shares of Docusign stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $46.02, for a total transaction of $1,208,025.00. Following the completion of the transaction, the chief executive officer directly owned 159,038 shares in the company, valued at approximately $7,318,928.76. This trade represents a 14.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Blake Grayson sold 15,000 shares of the business’s stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $60.00, for a total value of $900,000.00. Following the completion of the sale, the chief financial officer directly owned 126,429 shares in the company, valued at approximately $7,585,740. This represents a 10.61% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 90,602 shares of company stock valued at $4,323,749. 0.59% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Docusign

Several institutional investors and hedge funds have recently modified their holdings of the stock. Modus Advisors LLC bought a new position in Docusign in the 4th quarter worth about $27,000. Cary Street Partners Investment Advisory LLC increased its stake in Docusign by 309.5% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 561 shares of the company’s stock valued at $38,000 after purchasing an additional 424 shares in the last quarter. Basepoint Wealth LLC bought a new stake in Docusign during the 4th quarter valued at about $39,000. WealthCollab LLC raised its holdings in Docusign by 372.4% in the first quarter. WealthCollab LLC now owns 855 shares of the company’s stock worth $41,000 after buying an additional 674 shares during the last quarter. Finally, Virtus Advisers LLC purchased a new position in Docusign in the second quarter worth about $47,000. 77.64% of the stock is currently owned by institutional investors.

Trending Headlines about Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Quarterly results exceeded expectations. DocuSign reported revenue of $875.7 million, up 9.4% year over year and ahead of the $867.2 million consensus estimate. Adjusted earnings of $1.16 per share also surpassed expectations of approximately $1.08-$1.09. DocuSign Announces Second Quarter Fiscal 2027 Financial Results
• Positive Sentiment: Management raised its fiscal 2027 outlook. The company increased guidance for revenue, annual recurring revenue (ARR) and the percentage of ARR generated by its Intelligent Agreement Management (IAM) platform. Third-quarter revenue guidance of $886 million-$890 million was broadly in line with analyst expectations. DocuSign raises annual forecast as AI-powered contract tools gain traction
• Positive Sentiment: AI and IAM adoption are becoming key growth drivers. New AI-powered contract tools are gaining traction, while stronger retention and IAM momentum suggest DocuSign is broadening its addressable market beyond electronic signatures. CFO Blake Grayson said strengthening partnerships supported the higher ARR forecast.
• Positive Sentiment: DocuSign is opening its Model Context Protocol server to all AI agents globally on September 30. The initiative could make DocuSign’s agreement technology more accessible across agentic enterprise software ecosystems and support future platform usage. DocuSign Agreement Layer for the Agentic Enterprise Coming to Every Agent
• Positive Sentiment: Several analysts raised their price targets following the earnings report, including UBS to $70, BTIG to $75 and Citizens JMP to $86. Morgan Stanley also reportedly increased its target, while technical traders noted a bullish “golden cross.”
• Neutral Sentiment: Analyst opinion remains divided. Bank of America raised its target to $64 but retained an “underperform” rating; UBS maintained “neutral,” and Needham reiterated “hold.” This suggests some analysts view the recent rally as having already priced in much of the improvement.
• Negative Sentiment: The stock reversed some early gains despite the earnings beat. With shares trading well above their 200-day average and at a relatively elevated earnings multiple, investors may be concerned that expectations for AI-driven growth are becoming demanding.

About Docusign

Docusign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, Docusign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, Docusign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

Docusign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.